Get ready for an exciting announcement for the melanoma community

  • Days
  • Hours
  • Minutes

A Study to Estimate the Anti-Tumor Activity and Identify Potential Predictors of Response in Patients with Advanced Mucosal or Acral Lentiginous Melanoma Receiving Standard Nivolumab in Combination with Ipilimumab followed by Nivolumab Monotherapy

Melanoma Research Program at Georgetown University

Award Type Team Awards
Institution Georgetown University
Donor Support MRF Breakthrough Consortium Award